Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice

DSpace/Manakin Repository

Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice

Citable link to this page

 

 
Title: Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice
Author: Ding, Hanlu; Wang, Li; Wu, Xiongfei; Yan, Jun; He, Yani; Ni, Bing; Gao, Wenda; Zhong, Xuemei

Note: Order does not necessarily reflect citation order of authors.

Citation: Ding, Hanlu, Li Wang, Xiongfei Wu, Jun Yan, Yani He, Bing Ni, Wenda Gao, and Xuemei Zhong. 2009. “Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice.” Journal of Cellular and Molecular Medicine 14 (6b): 1717-1725. doi:10.1111/j.1582-4934.2009.00817.x. http://dx.doi.org/10.1111/j.1582-4934.2009.00817.x.
Full Text & Related Files:
Abstract: Abstract B-cell-activating factor (BAFF), a member of the tumour necrosis factor superfamily, plays a critical role in the maturation, homeostasis and function of B cells. In this study, we demonstrated the biological outcome of BAFF blockade in BXSB murine lupus model, using a soluble fusion protein consisting of human BAFF-R and human mutant IgG4 Fc. Mutation of Leu235 to Glu in IgG4 Fc eliminated antibody-dependent cell cytotoxicity (ADCC) and complement lysis activity, and generated a protein devoid of immune effector functions. Treatment of BXSB mice with BAFF-R-IgG4mut fusion protein for 5 weeks resulted in significant B-cell reduction in both the peripheral blood and spleen. Treated mice developed lower proteinuria, reduced glomerulonephritis and much delayed host death than untreated animals. Thus, BAFF blockade with BAFF-R-IgG4mut protein is an effective strategy to treat B-cell-mediated lupus-like pathology. Moreover, compared with other IgG isotypes with undesired effector functions, mutant IgG4 Fc should prove useful in constructing novel therapeutic reagents to block immune molecule signalling in various diseases.
Published Version: doi:10.1111/j.1582-4934.2009.00817.x
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829033/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:15035036
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters